Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Sabadell
Clinical trial register · Spain

Clinical Trials in Sabadell, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Corporacion Parc Tauli13 Janssen Research & Development, LLC13 Novartis Pharmaceuticals11 AbbVie9 Sanofi7
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Sabadell

183 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Corporacion Parc Tauli
Observational
100
Sabadell
2026-12-01
Not yet open
Fundacion Dexeus
Phase 4
154
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-10-15
Recruiting
Marc Badia
Not applicable
24
Sabadell
2026-09-30
Recruiting
Biocon Biologics UK PLC
Phase 1
120
Barcelona, Madrid, Murcia, Sabadell, Seville
2026-09-09
Not yet open
The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis
NCT07746843Mild Knee Osteoarthritis, Moderate Knee Osteoarthritis
BioRegen Biomedical (Changzhou) Co., Ltd
Not applicable
286
Sabadell
2026-09-01
Not yet open
Eli Lilly and Company
Phase 3
150
Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
2026-09
Not yet open
Fundacion Dexeus
Phase 4
240
Sabadell, Sant Cugat del Vallès, Barcelona, Tarragona
2026-09
Recruiting
Novartis Pharmaceuticals
Phase 3
188
Santiago Compostela, Sabadell, Seville
2026-08-04
Recruiting
Boehringer Ingelheim
Phase 3
448
Badalona, Barakaldo, Barcelona, Huelva, L'Hospitalet Del Llobregat, Madrid, Sabadell, Valencia
2026-07-27
Not yet open
Vall d'Hebron Institute of Oncology
Phase 2
150
Córdoba, Zaragoza, Santander, Barcelona, L'Hospitalet de Llobregat, Sabadell, Lugo, Ourense
2026-06
Recruiting
Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome
NCT07654114Fragile X Syndrome (FXS), Fragile X Syndrome
Connecta Therapeutics, S.L.
Phase 2
30
Barcelona, Sabadell
2026-05-21
Recruiting
Sanofi
Phase 4
300
Barcelona, A Coruña, Madrid, San Cristóbal de La Laguna, Málaga, Sabadell
2026-05-12
Recruiting
Impact of SMS Messaging on Participation in Colorectal Cancer Screening
NCT07628998Colorectal Neoplasms, Early Detection of Cancer
Corporacion Parc Tauli
Not applicable
10,084
Sabadell
2026-05-05
Recruiting
Home tDCS for the Treatment of Major Depression.
NCT07510880Major Depression Disorder
Ionclinics & Deionic SL
Not applicable
198
L'Hospitalet de Llobregat, Mataró, Sabadell
2026-04-14
Recruiting
AstraZeneca
Phase 3
245
Barcelona, Córdoba, Galdakao, Madrid, Sabadell, Santander, Seville, Valencia
2026-04-13
Recruiting
AI-TOP Study Artificial Intelligence for Trigger Optimization.
NCT07515118Infertility, Ovarian Stimulation, Artificial Intelligence
Fundacion Dexeus
Not applicable
644
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-04-08
Recruiting
Fundacion Dexeus
Phase 4
62
Sabadell, Sant Cugat del Vallès, Reus, Barcelona, Tarragona
2026-01-19
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Barcelona, Esplugues de Llobregat, Madrid, Manresa, Oviedo, Pamplona, Sabadell
2026-01-08
Active, closed
Hospital Son Llatzer
Observational
80
Palma de Mallorca, Sabadell
2026-01-01
Recruiting
Norgine
Phase 3
212
Ferrol, Palma de Mallorca, Sabadell, Madrid, Málaga
2025-12-29
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Palma de Mallorca, Badalona, Barcelona, Sabadell, Granada, Las Palmas de Gran Canaria, Lugo, Madrid
2025-12-22
Recruiting
AstraZeneca
Phase 2
320
Barcelona, Málaga, Sabadell, Santiago de Compostela, Valencia
2025-12-15
Recruiting
AbbVie
Phase 2/3
490
Santiago de Compostela, Sabadell, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Alava, Badalona, Barcelona, Madrid, Málaga, Oviedo, Palma, Sabadell
2025-12-09
Not yet open
Tofacitinib in Juvenile Idiopathic Arthritis
NCT07211932Juvenile Idiopathic Arthritis (JIA)
DrugTofacitinib
Consorci Sanitari de l'Alt Penedès i Garraf
Observational
58
Barcelona, Sabadell, Vilafranca del Penedès
2025-12
By invitation
Celldex Therapeutics
Phase 3
1,370
Alicante, Barcelona, Madrid, Sabadell, Villarreal de Huerva
2025-11-25
Recruiting
BioNTech SE
Phase 3
558
Badajoz, Barcelona, Córdoba, Madrid, Murcia, Pamplona, Sabadell, Valencia
2025-10-30
Recruiting
Universitat Autonoma de Barcelona
Not applicable
150
Sabadell
2025-10-22
Active, closed
Merck Sharp & Dohme LLC
Phase 2
185
Sabadell, Santander, Santiago de Compostela, Barcelona
2025-10-08
Not yet open
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 3
220
Pamplona, Barcelona, Palencia, Sabadell, Seville
2025-09-15
Recruiting
AstraZeneca
Phase 3
700
Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander
2025-08-06
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics
Phase 1/2
140
Madrid, Córdoba, Sabadell
2025-07-28
Recruiting
Celgene
Phase 3
400
Sabadell, Santander, Madrid, Valencia, Granada
2025-07-28
Recruiting
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase 3
190
Barcelona, Madrid, Sabadell, Santander
2025-07-16
Recruiting
Climb Bio, Inc.
Phase 1
30
Sabadell, A Coruña
2025-07-10
Recruiting
AbbVie
Phase 2
180
Sabadell, Seville, Bilbao, A Coruña, Córdoba, Madrid, Valencia
2025-06-20
Active, closed
4Moving Biotech
Phase 2
129
A Coruña, Alicante, Sabadell, Santiago de Compostela, Seville
2025-06-17
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
Barcelona, Sabadell
2025-06-10
Recruiting
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
NCT05881798Deep Vein Thrombosis, Venous Thromboembolism, Pulmonary Embolism
Cook Research Incorporated
Observational
82
Barcelona, Córdoba, Sabadell
2025-06-02
Recruiting
Intelligent Lung Support in the Intensive Care Unit
NCT06595602Mechanical Ventilation, Intensive Care Medicine
Technische Universität Dresden
Observational
530
Madrid, Sabadell
2025-05-25
Recruiting
EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial
NCT07041073Major Depression With Comorbid Anxiety Symptoms, Major Depressive Disorder (MDD)
Corporacion Parc Tauli
Not applicable
72
Sabadell
2025-05-19
Active, closed
Gilead Sciences
Phase 1
65
A Coruña, Barcelona, Madrid, Sabadell, Seville
2025-05-14
Recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Observational
100
Badalona, L'Hospitalet de Llobregat, Sabadell, Barcelona
2025-05-01
By invitation
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
NCT07070284Severe Community-Acquired Pneumonia (sCAP), Elderly Infection, Community-Acquired Infections, Health Care Quality, Access, and Evaluation
Joan Sabater-Riera
Observational
500
Seville, L'Hospitalet de Llobregat, Barcelona, Sabadell, Donostia / San Sebastian
2025-05-01
Recruiting
AbbVie
Observational
700
A Coruña, Badalona, Sabadell, Córdoba, Marbella, Pamplona, Seville, Manises
2025-03-28
Recruiting
Corporacion Parc Tauli
Observational
75
Sabadell
2025-03-25
Active, closed
Immutep S.A.S.
Phase 3
756
Badalona, Barcelona, Córdoba, Madrid, Málaga, Oviedo, Sabadell, Seville
2025-03-21
Active, closed
Celgene
Phase 3
960
Córdoba, Barcelona, Sabadell, Barakaldo, Santander, Lugo, Madrid, Majadahonda
2025-03-13
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Sabadell, Las Palmas de Gran Canaria, Madrid, Seville
2025-03-11
Recruiting
Takeda
Phase 3
1,088
Mérida, Sabadell, Santiago de Compostela, Málaga, Seville, Valencia
2025-03-03
Active, closed
Janssen Research & Development, LLC
Phase 3
552
A Coruña, Barcelona, Córdoba, Madrid, Málaga, Sabadell, Santander, Seville
2025-02-21
Recruiting
Early Discharge With Hospital-at-Home After Bariatric Surgery and Economic Evaluation.
NCT07782281Severe Obesity, Morbid Obesity Requiring Bariatric Surgery
Corporacion Parc Tauli
Observational
300
Sabadell
2025-02-15
Active, closed
Sanofi
Phase 3
231
Santiago de Compostela, Barcelona, Jerez de la Frontera, Majadahonda, Seville, Sabadell, Zaragoza
2025-02-12
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Cadiz, Badalona, Sabadell, Barcelona, Manises, Valencia, Madrid
2025-01-31
By invitation
Implementation of the Intravitreal Injection Administered by Nurses
NCT06511700Macular Edema, Macular Degeneration, Diabetic Macular Edema
Corporacion Parc Tauli
Observational
200
Sabadell
2025-01-15
Recruiting
Corporacion Parc Tauli
Observational
200
Sabadell
2025-01-07
Recruiting
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
NCT06955221Endometrioma, Ultrasound Therapy; Complications, Quality of Life, Pelvic Pain
Hospital Universitari de Bellvitge
Not applicable
288
Palma de Mallorca, Badalona, Igualada, L'Hospitalet de Llobregat, Martorell, Sabadell, Sant Boi de Llobregat, Viladecans
2025-01-01
Recruiting
Tesai Care SL
Not applicable
20
Barcelona, L'Hospitalet de Llobregat, Sabadell
2024-12-01
Recruiting
UCB Biopharma SRL
Phase 3
450
A Coruña, Badajoz, Barcelona, Castellon, Madrid, Málaga, Mérida, Sabadell
2024-11-21
Recruiting
Eli Lilly and Company
Phase 3
125
Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
2024-11-18
Recruiting
argenx
Phase 2
81
Barcelona, Córdoba, Sabadell
2024-11-11
Recruiting
Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology
NCT06603831Radius; Deformity, Hip Osteoarthritis, Hip Arthritis, Hip Arthropathy
Corporacion Parc Tauli
Not applicable
180
Sabadell
2024-10-21
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
600
A Coruña, Alcobendas, Bilbao, Castellon, Madrid, Málaga, Sabadell, Santiago de Compostela
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
A Coruña, Alcobendas, Bilbao, Castelló, Madrid, Málaga, Sabadell, Santiago de Compostela
2024-10-15
Active, closed
The Post Intensive Care Syndrome Follow-up and Management Study: The ICU Recovery Answers Project
NCT06504979Post Intensive Care Syndrome, ICU Survivors, ICU Families
Corporacion Parc Tauli
Not applicable
360
Sabadell
2024-10-02
Active, closed
University of the Balearic Islands
Not applicable
93
Palma de Mallorca, Sabadell
2024-09-30
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Sabadell, Santander, Majadahonda, Barcelona, Madrid, Seville, Valencia
2024-09-04
Active, closed
Gilead Sciences
Phase 3
640
A Coruña, Barcelona, Jaén, Madrid, Málaga, Palma, Sabadell, San Sebastián
2024-08-28
Recruiting
Sanofi
Phase 3
160
Santiago de Compostela, Barcelona, Majadahonda, Pamplona, Málaga, Sabadell, Santa Cruz de Tenerife, Valencia
2024-08-21
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 3
255
Majadahonda, Sabadell
2024-07-31
By invitation
Viatris Innovation GmbH
Phase 3
680
Sabadell, Santiago de Compostela, Seville, Valladolid
2024-07-30
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Santiago de Compostela, Barcelona, Bilbao, Majadahonda, Pamplona, Oviedo, Sabadell, Santa Cruz de Tenerife
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Sabadell, Alicante, Barcelona, Córdoba, Madrid, Salamanca, Villarreal de Huerva
2024-07-11
Recruiting
Fundacion Oncosur
Phase 2
78
Badalona, Barcelona, Sabadell, Santander, Cadiz, Madrid, Málaga, Barakaldo
2024-07-05
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Sabadell, Bilbao, A Coruña, Madrid, Seville, Valencia
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Sabadell, Santander, Manises, Madrid, Málaga, Valencia
2024-06-27
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Not applicable
540
Sabadell, Madrid, Murcia, Valencia
2024-06-27
Recruiting
AstraZeneca
Phase 3
240
A Coruña, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Sabadell, Valladolid
2024-06-20
Recruiting
Corporacion Parc Tauli
Observational
120
Sabadell
2024-05-01
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Badalona, Barcelona, Madrid, Málaga, Sabadell, Santander, Seville, Valencia
2024-04-09
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Córdoba, Sabadell, Valencia
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
90
Córdoba, Sabadell, Valencia
2024-03-13
By invitation
cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification Unit
NCT06838468Liver Disease Chronic, Cirrhosis, Detoxification, Alcohol Abuse/Dependence
Corporacion Parc Tauli
Observational
150
Sabadell
2024-03-06
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Madrid, Sabadell, Valencia
2024-01-19
By invitation
Sanofi
Phase 3
90
Santiago de Compostela, Barcelona, Esplugues de Llobregat, Sabadell, Jerez de la Frontera, Madrid, Valencia
2024-01-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Santiago de Compostela, Seville, Palma, Badalona, Sabadell, Terrassa, Santander, A Coruña
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
L'Hospitalet de Llobregat, Sabadell, Santander, Majadahonda, Oviedo, Barcelona, Cadiz, Girona
2023-12-11
Recruiting
Eikon Therapeutics
Phase 1/2
156
Sabadell, Madrid, Pamplona, Barcelona, Seville, Valencia
2023-12-11
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Sabadell, Santander, Majadahonda, Valencia, Barcelona, Madrid, Seville
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,898
Barcelona, Córdoba, L'Hospitalet de Llobregat, Lugo, Madrid, Sabadell, Valencia
2023-11-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Badalona, Sabadell, Bilbao, Santander, Vigo, A Coruña, Barcelona, Córdoba
2023-10-27
Recruiting
Biotest
Phase 3
590
Palma de Mallorca, Sabadell, Terrassa, Córdoba, Majadahonda, Pamplona, Oviedo, Barcelona
2023-09-09
Recruiting
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Not applicable
900
Santiago de Compostela, L'Hospitalet de Llobregat, Sabadell, A Coruña, Majadahonda, Oviedo, Alicante, Barcelona
2023-09-06
Recruiting
Ipsen
Phase 3
276
Barcelona, Madrid, Majadahonda, Málaga, Pontevedra, Sabadell, Seville, Valencia
2023-08-31
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Badalona, Barcelona, Córdoba, Madrid, Sabadell, Santiago de Compostela, Seville, Valencia
2023-08-30
Recruiting
AstraZeneca
Phase 3
231
Badalona, Barcelona, Esplugues de Llobregat (Barc), Madrid, Sabadell, Valencia, Villarreal
2023-08-24
Recruiting
Novartis Pharmaceuticals
Phase 4
700
L'Hospitalet de Llobregat, Sabadell, Majadahonda, Barcelona, Madrid, Valencia
2023-08-14
Recruiting
Corporacion Parc Tauli
Observational
120
Sabadell
2023-06-01
Recruiting
Fundación Española de Hematología y Hemoterapía
Observational
210
Vitoria-Gasteiz, Almería, Palma de Mallorca, Sabadell, Burgos, Valdepeñas, Girona, Granada
2023-05-30
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Esplugues, Sabadell, Barcelona, Córdoba, Madrid, Málaga
2023-05-11
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
470
Barcelona, Madrid, Sabadell, Zamora
2023-05-02
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Ciutat Vella, Horta-Guinardó, L'Hospitalet de Llobregat, Sabadell, Girona, Santa Cruz de Tenerife
2023-04-30
Active, closed
Sanofi
Phase 2
999
Badalona, Sabadell, Alicante, Córdoba, Madrid, Valencia
2023-04-03
Recruiting
Closed Loop Oxygen Control in INtubated Critically Ill Patients
NCT06829732Hypoxemic Acute Respiratory Failure
Parc Taulí Hospital Universitari
Not applicable
46
Sabadell
2023-04-01
Active, closed
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT05625958Glaucoma, Open-Angle, Glaucoma, Narrow Angle
Ciliatech
Not applicable
29
Barcelona, Madrid, Sabadell, Zaragoza
2023-03-23
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
20
Esplugues de Llobregat, Sabadell, Barcelona, Seville
2023-01-23
Recruiting
Technische Universität Dresden
Observational
318,542
Sabadell, Seville
2023-01-01
By invitation
Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
NCT06840652Alcoholic Cirrhosis, Alcohol Abstinence, Alcohol Withdrawal, Medication Toxicity
DrugBaclofen
Corporacion Parc Tauli
Observational
120
Sabadell
2022-12-22
Recruiting
Pfizer
Phase 2
36
Santiago de Compostela, Sabadell, Barcelona, Córdoba
2022-12-16
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
A Coruña, Badalona, Barcelona, Córdoba, Jaén, Madrid, Málaga, Sabadell
2022-12-13
Recruiting
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Not applicable
40
Badalona, L'Hospitalet de Llobregat, Manresa, Sabadell, Sant Joan Despí, Terrassa, Cáceres, Girona
2022-11-29
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Barakaldo, Barcelona, Jerez de la Frontera, Madrid, Murcia, Sabadell, Seville, Valencia
2022-11-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Barcelona, Madrid, Murcia, Sabadell, Seville, Valencia
2022-11-08
Recruiting
Regeneron Pharmaceuticals
Observational
500
Málaga, Sabadell, Jerez de la Frontera, Castellon, Ferrol, Vigo, Almería, Jaén
2022-10-26
Recruiting
GBG Forschungs GmbH
Observational
400
Córdoba, Bilbao, Santa Cruz de Tenerife, Badalona, Barcelona, Lleida, Sabadell, Cáceres
2022-10-12
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Barcelona, Madrid, Pamplona, Pontevedra, Sabadell, Santander, Torrejón de Ardoz, Vigo
2022-09-19
Recruiting
Novartis Pharmaceuticals
Phase 2
42
Esplugues, Sabadell, Mérida, Barcelona
2022-08-29
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 4
360
Alicante, Seville, Palma de Mallorca, Barcelona, Sabadell, Terrassa, Barakaldo, Santander
2022-08-17
Active, closed
AbbVie
Observational
785
L'Hospitalet de Llobregat, Sabadell, Las Palmas de Gran Canaria, Gijón, San Cristóbal de La Laguna, Seville, Galdakao, Almería
2022-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Madrid, Pamplona, Pontevedra, Sabadell, Santander, Torrejón de Ardoz
2022-07-22
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
372
Sabadell, Barcelona, Madrid, Seville
2022-05-03
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4
306
Palma de Mallorca, L'Hospitalet de Llobregat, Sabadell, Barakaldo, Jerez de la Frontera, Puerto Real, Donostia / San Sebastian, Logroño
2022-04-28
Active, closed
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
NCT05192616Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent
iVascular S.L.U.
Observational
241
Barcelona, Bilbao, Sabadell
2022-04-27
Active, closed
Effectiveness of Educational Intervention on Sustainable Breastfeeding: The GREEN MOTHER Project
NCT05729581Healthy Diet, Health Behaviour, Environmental-Pollution-Related Condition, Mothers
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Not applicable
429
Sabadell
2022-04-11
Recruiting
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Not applicable
36
Barcelona, Sabadell, Girona
2022-04-04
Active, closed
AstraZeneca
Phase 3
1,035
Barcelona, Córdoba, Lugo, Madrid, Málaga, Sabadell, Seville
2022-03-25
Recruiting
Pfizer
Phase 3
640
Sabadell, Valladolid, Vigo, Valencia, Madrid, Seville
2022-02-28
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Sabadell, Pamplona, Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Málaga
2021-12-02
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Ferrol, Santiago Compostela, Seville, Mallorca, Palma, el Prat de Llobregat, L'Hospitalet de Llobregat, Sabadell
2021-11-23
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Barcelona, Sabadell, Sant Pere de Ribes, Terrassa, Marbella, Valladolid, Madrid
2021-11-22
Recruiting
Hospital General Universitario de Alicante
Phase 3
332
Santiago de Compostela, Alicante, Elche, Barcelona, L'Hospitalet de Llobregat, Sabadell, Santander, Granada
2021-11-10
Active, closed
Sanofi
Phase 2
109
Sabadell, Madrid, Valencia, Valladolid
2021-11-10
Active, closed
Cullinan Therapeutics Inc.
Phase 1
440
Las Palmas de Gran Canaria, Barcelona, Madrid, Pamplona, Sabadell
2021-10-29
Recruiting
Spanish Registry of Patients With IgM Monoclonal Gammopathies
NCT05093153Waldenstrom Macroglobulinemia
Fundación Española de Hematología y Hemoterapía
Observational
1,000
Mérida, Palma, Palma de Mallorca, Badalona, Barcelona, Manresa, Sabadell, Córdoba
2021-10-01
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma, Non-small Cell Lung Cancer
Guardant Health, Inc.
Observational
2,285
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela
2021-09-07
Active, closed
Janssen Research & Development, LLC
Phase 4
411
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Madrid, Málaga, Sabadell
2021-08-30
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Elche, Palma de Mallorca, Badalona, Manresa, Sabadell, Santiago de Compostela, Jerez de la Frontera, Castellon de LA Plana/castello de LA Plana
2021-08-27
Active, closed
Inventiva Pharma
Phase 3
1,000
Almería, Badalona, Palma de Mallorca, Barcelona, Sabadell, León, Madrid, Majadahonda
2021-08-19
By invitation
UCB Biopharma SRL
Phase 3
760
Barcelona, Málaga, Sabadell, Vigo
2021-07-27
Active, closed
Bristol-Myers Squibb
Phase 3
670
A Coruña, Córdoba, Madrid, Sabadell
2021-07-13
Active, closed
Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease
NCT04595266Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer
DrugsFolfox·Bevacizumab
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2
48
Barcelona, Sabadell, Madrid, Pamplona, Valencia
2021-06-29
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
A Coruña, Badalona, Barcelona, Córdoba, LHospitalet de Llobregat, Madrid, Pamplona, Sabadell
2021-06-24
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
L'Hospitalet de Llobregat, Sabadell, Majadahonda, El Palmar, Barcelona, Madrid, Valencia
2021-06-09
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Córdoba, Esplugues de Llobregat, Sabadell, Valencia
2021-05-26
Active, closed
Bristol-Myers Squibb
Phase 3
681
Barcelona, Madrid, Sabadell, Santander, Seville
2021-05-21
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Elche, Badalona, Sabadell, Jerez de la Frontera, Vigo, San Cristóbal de La Laguna, Bilbao, Granada
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Sabadell, Santander, Córdoba, Donostia / San Sebastian, Barcelona, Madrid, Seville, Valencia
2021-05-03
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Barcelona, Valladolid, Bilbao, Galdakao, Jaén, Madrid, Manresa, Sabadell
2021-04-24
Recruiting
Boston Scientific Corporation
Observational
5,000
Sabadell
2021-03-29
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
DrugsIrinotecan·Gemcitabine
Artios Pharma Ltd
Phase 1/2
542
Elche, Sabadell, Santander, Barcelona, Lleida, Madrid, Pozuelo de Alarcón, El Palmar
2021-01-27
Active, closed
Janssen Research & Development, LLC
Phase 3
518
A Coruña, Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Sabadell, Santander
2020-12-07
Recruiting
Integrative Diagnosis for SCD and Other RADs
NCT07206095Sickle Cell Disease, Thalassaemia, Congenital Dyserythropoietic Anemia (CDA), Enzyme Disorder; Anemia
Hospital Universitari Vall d'Hebron Research Institute
Observational
200
Barcelona, Esplugues de Llobregat, Granollers, Mataró, Sabadell, Terrassa, Lleida
2020-11-13
Active, closed
Bayer
Phase 3
402
Elche, Manacor, Palma de Mallorca, Sabadell, Alcorcón, Barcelona, Cáceres, Córdoba
2020-10-20
Active, closed
Janssen Research & Development, LLC
Phase 3
696
A Coruña, Barcelona, Castellon, Girona, Jerez de la Frontera, Madrid, Málaga, Sabadell
2020-09-23
Active, closed
MedImmune LLC
Phase 1
67
Barcelona, Córdoba, Madrid, Sabadell, Seville, Valencia
2020-08-05
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Barcelona, Córdoba, Lugo, Madrid, Manresa, Pamplona, Sabadell, Santander
2020-03-30
Active, closed
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922Primary Glioblastoma, Glioblastoma Multiforme
DrugLAM561
Laminar Pharmaceuticals
Phase 2/3
144
Córdoba, Seville, Barcelona, Madrid, Valencia, Sabadell
2019-12-01
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma, Pamplona, Sabadell
2019-09-18
Active, closed
Spanish Oncology Genito-Urinary Group
Phase 2
39
Manresa, Sabadell, Reus, Granada, Lugo, Madrid, Ourense, Oviedo
2019-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
437
Barcelona, Córdoba, Madrid, Pamplona, Sabadell, Santander, Santiago Compostela, Seville
2019-06-21
Active, closed
Effectiveness of Treatments for Massive Rotator Cuff Tears: Mixed Methodology.
NCT05780229Massive Rotator Cuff Tears, Shoulder Disease
Parc de Salut Mar
Observational
200
Sabadell, Barcelona, Madrid
2019-03-27
Active, closed
AbbVie
Phase 3
964
Badalona, Sabadell, A Coruña, Almería, Barcelona, Madrid, Valencia
2019-03-25
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Sabadell, Santiago de Compostela, Barcelona, Madrid, Seville
2019-03-20
Active, closed
Novartis Pharmaceuticals
Phase 2
248
Granada, Sabadell, Manises, Barcelona, Las Palmas GC, Valencia
2019-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
765
A Coruña, Barcelona, Jerez de la Frontera, Madrid, Málaga, Pozuelo de Alarcón, Sabadell, Santander
2019-01-25
Active, closed
AbbVie
Phase 3
1,242
Ferrol, Sabadell, Majadahonda, Vigo, Gijón, Barcelona, Córdoba, Madrid
2018-08-28
Active, closed
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
Grupo Español Multidisciplinar de Melanoma
Observational
400
Alcoy, Granada, Málaga, Barcelona, Sabadell, Vitoria-Gasteiz, Santander, Burgos
2018-08-07
Recruiting
Fundación Sociedad Española de Oncologia Médica
Observational
700
Alcoy, Elche, Palma, L'Hospitalet de Llobregat, Sabadell, Sant Joan Despí, Santander, Jerez de la Frontera
2018-07-04
Active, closed
AbbVie
Phase 3
1,336
Ferrol, L'Hospitalet de Llobregat, Sabadell, Majadahonda, Bilbao, Barcelona, Madrid, Salamanca
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
Pfizer
Phase 3
1,054
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Sabadell, El Palmar, Barcelona, Madrid
2017-12-18
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Barcelona, Sabadell
2017-10-26
Active, closed
ECOG-ACRIN Cancer Research Group
Phase 3
108,508
Sabadell
2017-09-28
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Alcorcón, Barcelona, Bilbao, Cartagena, Córdoba, Las Palmas de Gran Canaria, Pamplona, Sabadell
2017-09-25
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo
2017-09-05
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Barcelona, Madrid, Pamplona, Sabadell, Salamanca
2015-10
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
AbbVie
Observational
1,446
A Coruña, Ferrol, Santiago de Compostela, Palma de Mallorca, Badalona, Esplugues de Llobregat, Sabadell, Leganés
2014-08-28
Active, closed
Zimmer POLAR Persona - TKA (EMEA Study)
NCT02337244Severe Knee Pain, Severe Knee Disability, Osteoarthritis, Rheumatoid Arthritis
Zimmer, GmbH
Observational
777
Sabadell, Zaragoza
2013-11-18
Active, closed
UNICANCER
Phase 3
1,173
Badalona, Barcelona, Girona, Madrid, Manresa, Málaga, Sabadell, Salamanca
2013-11-13
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
A Coruña, Barcelona, Alcorcón, Vigo, Seville, Madrid, Sabadell, Valencia
1991-04-01
Rows per page Showing 1–183 of 183
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/sabadell

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 183 of those studies with a site in Sabadell.

How many clinical trials are recruiting in Sabadell?

86 of the 183 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 8 have not yet opened recruitment, 81 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Sabadell), 183 studies
PhaseStudiesRecruitingShare
Phase 3853046.4%
Observational331918%
Not applicable221712%
Phase 221911.5%
Phase 4844.4%
Phase 1723.8%
Phase 1/2542.7%
Phase 2/3211.1%

Most active sponsors

Lead sponsors with the most studies (Sabadell)
Lead sponsorStudiesRecruiting
Corporacion Parc Tauli138
Janssen Research & Development, LLC132
Novartis Pharmaceuticals115
AbbVie93
AstraZeneca75
Sanofi72
Eli Lilly and Company43
Fundacion Dexeus42
Bristol-Myers Squibb30
Hoffmann-La Roche30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.